坏疽性脓皮病
医学
皮肤病科
炎症性肠病
溃疡性结肠炎
丘疹
脓皮病
外科
疾病
内科学
病变
作者
Emanual Maverakis,Chelsea Ma,Kanade Shinkai,David Fiorentino,Jeffrey P. Callen,Uwe Wollina,Angelo Valerio Marzano,D. Wallach,Kyoungmi Kim,Courtney R. Schadt,Anthony D. Ormerod,Maxwell A. Fung,Andrea Steel,Forum Patel,Rosie Qin,Fiona E. Craig,Hywel C Williams,Frank C. Powell,Alexander A. Merleev,Michelle Y. Cheng
出处
期刊:JAMA Dermatology
[American Medical Association]
日期:2018-02-14
卷期号:154 (4): 461-461
被引量:382
标识
DOI:10.1001/jamadermatol.2017.5980
摘要
Pyoderma gangrenosum is a rare inflammatory skin condition that is difficult to diagnose. Currently, it is a "diagnosis of exclusion," a definition not compatible with clinical decision making or inclusion for clinical trials.To propose and validate diagnostic criteria for ulcerative pyoderma gangrenosum.Diagnostic criteria were created following a Delphi consensus exercise using the RAND/UCLA Appropriateness Method. The criteria were validated against peer-reviewed established cases of pyoderma gangrenosum and mimickers using k-fold cross-validation with methods of multiple imputation.Delphi exercise yielded 1 major criterion-biopsy of ulcer edge demonstrating neutrophilic infiltrate-and 8 minor criteria: (1) exclusion of infection; (2) pathergy; (3) history of inflammatory bowel disease or inflammatory arthritis; (4) history of papule, pustule, or vesicle ulcerating within 4 days of appearing; (5) peripheral erythema, undermining border, and tenderness at ulceration site; (6) multiple ulcerations, at least 1 on an anterior lower leg; (7) cribriform or "wrinkled paper" scar(s) at healed ulcer sites; and (8) decreased ulcer size within 1 month of initiating immunosuppressive medication(s). Receiver operating characteristic analysis revealed that 4 of 8 minor criteria maximized discrimination, yielding sensitivity and specificity of 86% and 90%, respectively.This Delphi exercise produced 1 major criterion and 8 minor criteria for the diagnosis of ulcerative pyoderma gangrenosum. The criteria may serve as a guideline for clinicians, allowing for fewer misdiagnoses and improved patient selection for clinical trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI